Udugamasooriya DG - Search Results

1

A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells.

Shukla SP, Raymond A, Rustagi V, Kedika SR, Tran O, Wang L, Guo B, Udugamasooriya DG. Shukla SP, et al. Among authors: udugamasooriya dg. Bioorg Chem. 2021 Nov;116:105340. doi: 10.1016/j.bioorg.2021.105340. Epub 2021 Sep 8. Bioorg Chem. 2021. PMID: 34530236 Free PMC article.

2

Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.

Desai TJ, Toombs JE, Minna JD, Brekken RA, Udugamasooriya DG. Desai TJ, et al. Among authors: udugamasooriya dg. Oncotarget. 2016 May 24;7(21):30678-90. doi: 10.18632/oncotarget.8929. Oncotarget. 2016. PMID: 27120792 Free PMC article.

3

Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.

Singh J, Shukla SP, Desai TJ, Udugamasooriya DG. Singh J, et al. Among authors: udugamasooriya dg. Bioorg Med Chem. 2016 Sep 15;24(18):4470-4477. doi: 10.1016/j.bmc.2016.07.045. Epub 2016 Jul 21. Bioorg Med Chem. 2016. PMID: 27485601 Free PMC article.

4

On-bead combinatorial synthesis and imaging of europium(III)-based paraCEST agents aids in identification of chemical features that enhance CEST sensitivity.

Singh J, Rustagi V, Zhang S, Sherry AD, Udugamasooriya DG. Singh J, et al. Among authors: udugamasooriya dg. Magn Reson Chem. 2017 Aug;55(8):747-753. doi: 10.1002/mrc.4588. Epub 2017 Mar 24. Magn Reson Chem. 2017. PMID: 28220538 Free PMC article.

5

A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.

Desai TJ, Udugamasooriya DG. Desai TJ, et al. Among authors: udugamasooriya dg. Biochem Biophys Res Commun. 2017 Apr 29;486(2):545-550. doi: 10.1016/j.bbrc.2017.03.083. Epub 2017 Mar 18. Biochem Biophys Res Commun. 2017. PMID: 28322795 Free PMC article.

6

A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.

Shukla SP, Manarang JC, Udugamasooriya DG. Shukla SP, et al. Among authors: udugamasooriya dg. Eur J Med Chem. 2017 Sep 8;137:1-10. doi: 10.1016/j.ejmech.2017.05.040. Epub 2017 May 19. Eur J Med Chem. 2017. PMID: 28551176 Free PMC article.

7

A mini-library system to investigate non-essential residues of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.

Shukla SP, Udugamasooriya DG. Shukla SP, et al. Among authors: udugamasooriya dg. Medchemcomm. 2017 Dec 1;8(12):2208-2215. doi: 10.1039/C7MD00372B. Epub 2017 Oct 24. Medchemcomm. 2017. PMID: 29527284 Free PMC article.

8

Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase.

Kedika SR, Udugamasooriya DG. Kedika SR, et al. Among authors: udugamasooriya dg. Org Biomol Chem. 2018 Sep 11;16(35):6443-6449. doi: 10.1039/c8ob01406j. Org Biomol Chem. 2018. PMID: 30140808

9

Identification of side arm-modified DOTA scaffolds as multi-site binding ligands for cancer cells over normal cells.

Rustagi V, Udugamasooriya DG. Rustagi V, et al. Among authors: udugamasooriya dg. Bioorg Med Chem Lett. 2019 Oct 1;29(19):126619. doi: 10.1016/j.bmcl.2019.08.023. Epub 2019 Aug 12. Bioorg Med Chem Lett. 2019. PMID: 31431362

10

Design of a dual ERK5 kinase activation and autophosphorylation inhibitor to block cancer stem cell activity.

Kedika SR, Shukla SP, Udugamasooriya DG. Kedika SR, et al. Among authors: udugamasooriya dg. Bioorg Med Chem Lett. 2020 Dec 1;30(23):127552. doi: 10.1016/j.bmcl.2020.127552. Epub 2020 Sep 15. Bioorg Med Chem Lett. 2020. PMID: 32946922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters